Heart attack: The subtle and often overlooked warning sign of the dangerous condition

HEART attacks are insidious conditions as they are not always obvious to the person, however, they are major medical emergencies and one should do all they can to keep themselves informed of potential hidden signs in the body. There is a subtle and often overlooked symptom of a heart attack. What is it?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

Authors: Qin C, Wu XL, Gu J, Du D, Guo Y Abstract BACKGROUND The relationship between endoplasmic reticulum and mitochondria during acute myocardial ischemic injury is still unclear. Our study aimed to define the dynamics of endoplasmic reticulum stress and mitochondrial dysfunction during acute ischemic injury. MATERIAL AND METHODS A rat model of acute myocardial infarction and hypoxic cardiomyocytes were used in this study. Groups were set at 0 hours, 1 hour, 2 hours, 4 hours, and 6 hours after ischemic injury for both in vivo and in vitro studies. ATF6 and GRP-78 were examined to indicate endoplasmic reticulum s...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Photo credit Prion Guillaume Iwza Dear Carol: My dad’s nearly 80 and was told during an appointment with his doctor last winter that he’s a likely candidate for future heart bypass surgery. This is no emergency, but we are trying to help him decide what to do. I worry about him having a heart attack, but he also has several other health problems to consider. Now, the risk of coronavirus has made everything scarier. He says that he’s leaning against surgery because of all the risks. My brother says that we need to “force” him to have the surgery when the doctor says he’s ready. My sister ...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
Publication date: Available online 22 May 2020Source: Revista Española de Cardiología (English Edition)Author(s): María Rubini Giménez, Karin Wildi, Desiree Wussler, Luca Koechlin, Jasper Boeddinghaus, Thomas Nestelberger, Patrick Badertscher, Raphael Sedlmayer, Christian Puelacher, Tobias Zimmermann, Jeanne du Fay de Lavallaz, Pedro Lopez-Ayala, Kathrin Leu, Katharina Rentsch, Òscar Miró, Beatriz López, F. Javier Martín-Sánchez, José Bustamante, Damian Kawecki, Jiri Parenica
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research
HEART attacks can be life-threatening, so spotting symptoms of the condition is very important - the earlier the better. A doctor recommends six early warning signs of the condition to look out for.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
CONCLUSION: For patients with ULMCA disease and LVSD, there was no significant difference between DES and CABG in terms of efficacy and safety. Treatment with DES was an acceptable alternative to CABG. PMID: 32435839 [PubMed - as supplied by publisher]
Source: Herz - Category: Cardiology Tags: Herz Source Type: research
Treatment with beta-blockers is currently recommended after myocardial infarction (MI). The evidence relies on trials conducted decades ago before implementation of revascularization and contemporary medical t...
Source: Trials - Category: General Medicine Authors: Tags: Study protocol Source Type: research
A significant amount of clinical and research interest in thrombosis is focused on large vessels (e.g., stroke, myocardial infarction, deep venous thrombosis, etc.); however, thrombosis is often present in the microcirculation in a variety of significant human diseases, such as disseminated intravascular coagulation, thrombotic microangiopathy, sickle cell disease, and others. Further, microvascular thrombosis has recently been demonstrated in patients with COVID-19, and has been proposed to mediate the pathogenesis of organ injury in this disease.
Source: Translational Research - Category: Research Authors: Tags: Review Article Source Type: research
DiscussionDANBLOCK is a randomized clinical trial investigating the effect of long-term beta-blocker therapy after myocardial infarction in patients without heart failure and reduced LVEF. Results from the trial will add important scientific evidence to inform future clinical guidelines.Trial registrationClinicaltrials.gov,NCT03778554. Registered on 19 December 2018.European Clinical Trials Database,2018-002699-42, registered on 28 September 2018.
Source: Trials - Category: Research Source Type: clinical trials
FRIDAY, May 22, 2020 (American Heart Association News) -- High blood pressure is one of the top risk factors for heart attack and stroke. It's also common among people who develop severe symptoms of COVID-19. So, with more people at home practicing...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
FRIDAY, May 22, 2020 -- In Northern California, the incidence of hospitalization for acute myocardial infarction decreased during the COVID-19 pandemic period, according to a letter to the editor published online May 19 in the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Emergency Medicine | Health | Heart | Heart Attack | Warnings